Brief: Celularity Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update
31/03/2022 21:56
March 31 (Reuters) - Celularity Inc CELU.O :
* CELULARITY REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.03
* Q4 REVENUE $4.9 MILLION
Source text for Eikon: ID:nGNX1hhy3n
Further company coverage: CELU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform